Porcine Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1063340
  • May 2021
  • Pharmaceuticals
  • 134 Pages
The global Porcine Vaccine market research report provides complete study and detail analysis of the market. This study includes forecast analysis of the market which is based on global and regional level, whereas the research reports the provides forecast data from 2020-2028 and historic of 2018 and 2019. All the values are based on revenue USD Million. Moreover, the market research report describes various segments of the Porcine Vaccine market based on its types, applications and end-use industry. The applications of the market are explained in different industry verticals with reference to major countries across the globe. Along with this, the research report also covers all the major players that are operating in the global Porcine Vaccine market. These major players of the market are further studied and analyzed based on various parameters, such as annual market revenue, annual sales of the company, marketing strategy, historic growth and shipment volumes. Based on all the company’s insights, the market research analyst also suggests business strategy and marketing plans for improving the market position of existing participants of Porcine Vaccine market.
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Bayer AG, Bimeda Animal Health, Boehringer Ingelheim GmbH, Ceva Sante Animale, Eli Lilly and Company, Merck and Co., Inc., Sanofi S.A, Vetoquinol, Zoetis, Inc., Hipra, Elanco, Formosa Biomedical Inc., Shoken Pharmaceutical Co., Ltd, MSD Animal Health
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Impact Analysis
The analysis of covid-19 is based on the impact of the current pandemic situation on market scenarios. This includes impact of covid-19 outbreak on overall revenue, market segments as well as regional market. The report also puts light on detailed impact analysis by taking into consideration all the government policies imposed during the pandemic situation, temporary shutdown of manufacturing units, current state of supply chain and distributors, and its future impacts on the growth of overall market. The market study will assist user to understand the global demand and impose strategic business plans to compete with the peers.

Apart from this, the market research report also covers drivers and restraints for the global Porcine Vaccine market and their impact on the demand and supply during the forecast period. Along with this, the research report also provides Porcine Vaccine market trends and opportunities that are based on regional and global level. Furthermore, the market research report also provides the major distributors and manufacturers that are operating in all the key region across the world. The researched data provided in the report is widely used by various industry players to strengthen their distribution channel and improve the geographical reach. In addition, the report also covers all the major players of the global Porcine Vaccine market and its key offerings and solutions. The report also provides recent mergers and acquisitions of these key players.

The data which is provided in the market research report is analyzed and evaluated with the help of various marketing tools, such as SWOT analysis, Poster’s Five Force analysis, PESTEL analysis, value chain analysis, player positioning analysis and market share analysis. Therefore, this analysis tools helps the analyst to evaluate the Porcine Vaccine market based on various parameters such as capital investments, impact of consumer’s preferences, economies of scale, manufacturing rights and patents, existing distribution channels, switching costs, government regulations and brand loyalty.

Major Key Players for Global Porcine Vaccine Market:
The Porcine Vaccine market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Bayer AG, Bimeda Animal Health, Boehringer Ingelheim GmbH, Ceva Sante Animale, Eli Lilly and Company, Merck and Co., Inc., Sanofi S.A, Vetoquinol, Zoetis, Inc., Hipra, Elanco, Formosa Biomedical Inc., Shoken Pharmaceutical Co., Ltd, MSD Animal Health

Porcine Vaccine Market Segment Analysis:
By Technology
Inactivated Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
DNA Vaccines
Disease Indication
Diarrhea
Swine Influenza
Arthritis
Bordatella Rhinitis
Porcine Reproductive and Respiratory Virus
PRRSV
Porcine Circovirus Associated Disease
PCVAD
Others
End User
Veterinary Hospitals
Hog/Pig Production Farm

Geographic Coverage for Porcine Vaccine Market:
The market research report on global Porcine Vaccine market offers complete analysis across various regions across the world. The Porcine Vaccine market is distributed into various regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The global leading market share as per the region is evaluated after considering Porcine Vaccine market revenue, sales, shares, recent developments, innovations and growth rates. This section of regional analysis provides widespread evaluation of the industry from various countries and regions.

North America Porcine Vaccine Market Value and Forecast
  • US
  • Canada
Europe Porcine Vaccine Market Value and Forecast
  • UK
  • Germany
  • France
  •  Rest of Europe
Asia Pacific Porcine Vaccine Market Value and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Porcine Vaccine Market Value and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Porcine Vaccine Market Value and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa


Key highlights of the Porcine Vaccine market report:
  • The report provides key trends of the global Porcine Vaccine market
  • The report also covers consumer preferences and current industry growth
  • Key products or solutions offered by the main players in the Porcine Vaccine industry
  • The report covers all the recent developments of the Porcine Vaccine market and helps to provide current industry updates
  • The report covers a detailed look over the global Porcine Vaccine Industry and provides with significant actionable insights
  • The Porcine Vaccine market estimation from 2020-2028 and historical data for 2018 and 2019
  • The market study also provides data on changing market dynamics, market intelligence, current and future market trends
  • The report also analyses the microeconomic and macroeconomic factors that are affecting the global Porcine Vaccine market
  • In-depth analysis of the market’s competitive landscape and detailed information about the vendors
  • The report also offers key market drivers, restrains, trends and opportunities with present and future impact on the market
  • Detailed information about the major players or manufacturers of the global Porcine Vaccine market
  • Comprehensive analysis of the Porcine Vaccine market segments based on its types, applications and end-use industry
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Porcine Vaccine market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Porcine Vaccine market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

      2.  Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Porcine Vaccine market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Porcine Vaccine market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

      3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Porcine Vaccine market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Bayer AG
  • Bimeda Animal Health
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Eli Lilly and Company
  • Merck and Co., Inc.
  • Sanofi S.A
  • Vetoquinol
  • Zoetis, Inc.
  • Hipra
  • Elanco
  • Formosa Biomedical Inc.
  • Shoken Pharmaceutical Co., Ltd
  • MSD Animal Health
  • Inactivated Vaccines
  • Live Attenuated Vaccines
  • Toxoid Vaccines
  • Recombinant Vaccines
  • Conjugate Vaccines
  • DNA Vaccines
  • Veterinary Hospitals
  • Hog/Pig Production Farm

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Porcine Vaccine Market Snapshot
          2.1.1. Global Porcine Vaccine Market By Technology,2019
               2.1.1.1.Inactivated Vaccines
               2.1.1.2.Live Attenuated Vaccines
               2.1.1.3.Toxoid Vaccines
               2.1.1.4.Recombinant Vaccines
               2.1.1.5.Conjugate Vaccines
               2.1.1.6.DNA Vaccines
          2.1.2. Global Porcine Vaccine Market By End User,2019
               2.1.2.1.Veterinary Hospitals
               2.1.2.2.Hog/Pig Production Farm
          2.1.3. Global Porcine Vaccine Market By End-use,2019
          2.1.4. Global Porcine Vaccine Market By Geography,2019

3. Global Porcine Vaccine Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Porcine Vaccine Market Size (US$), By Technology, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Technology, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Technology, 2020
     4.2. Global Porcine Vaccine Market Size (US$), By Technology, 2018 – 2028

5. Global Porcine Vaccine Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Porcine Vaccine Market Size (US$), By End User, 2018 – 2028

6. Global Porcine Vaccine Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Porcine Vaccine Market Size (US$), By End-use, 2018 – 2028

7. Global Porcine Vaccine Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Porcine Vaccine Market Analysis, 2018 – 2028 
          7.2.1. North America Porcine Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Porcine Vaccine Market Size (US$), By Technology, 2018 – 2028
          7.2.3. North America Porcine Vaccine Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Porcine Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Porcine Vaccine Market Analysis, 2018 – 2028 
          7.3.1.  Europe Porcine Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Porcine Vaccine Market Size (US$), By Technology, 2018 – 2028
          7.3.3. Europe Porcine Vaccine Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Porcine Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Porcine Vaccine Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Porcine Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Porcine Vaccine Market Size (US$), By Technology, 2018 – 2028
          7.4.3. Asia Pacific Porcine Vaccine Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Porcine Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Porcine Vaccine Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Porcine Vaccine Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Porcine Vaccine Market Size (US$), By Technology, 2018 – 2028
          7.5.3. Latin America Porcine Vaccine Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Porcine Vaccine Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Porcine Vaccine Market Analysis, 2018 – 2028 
          7.6.1.  MEA Porcine Vaccine Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Porcine Vaccine Market Size (US$), By Technology, 2018 – 2028
          7.6.3. MEA Porcine Vaccine Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Porcine Vaccine Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Porcine Vaccine Providers
        8.4.1 Bayer AG
                8.4.1.1 Business Description
                8.4.1.2 Bayer AG Geographic Operations
                8.4.1.3 Bayer AG Financial Information
                8.4.1.4 Bayer AG Product Positions/Portfolio
                8.4.1.5 Bayer AG Key Developments
        8.4.2 Bimeda Animal Health
                8.4.2.1 Business Description
                8.4.2.2 Bimeda Animal Health Geographic Operations
                8.4.2.3 Bimeda Animal Health Financial Information
                8.4.2.4 Bimeda Animal Health Product Positions/Portfolio
                8.4.2.5 Bimeda Animal Health Key Developments
        8.4.3 Boehringer Ingelheim GmbH
                8.4.3.1 Business Description
                8.4.3.2 Boehringer Ingelheim GmbH Geographic Operations
                8.4.3.3 Boehringer Ingelheim GmbH Financial Information
                8.4.3.4 Boehringer Ingelheim GmbH Product Positions/Portfolio
                8.4.3.5 Boehringer Ingelheim GmbH Key Developments
        8.4.4 Ceva Sante Animale
                8.4.4.1 Business Description
                8.4.4.2 Ceva Sante Animale Geographic Operations
                8.4.4.3 Ceva Sante Animale Financial Information
                8.4.4.4 Ceva Sante Animale Product Positions/Portfolio
                8.4.4.5 Ceva Sante Animale Key Developments
        8.4.5 Eli Lilly and Company
                8.4.5.1 Business Description
                8.4.5.2 Eli Lilly and Company Geographic Operations
                8.4.5.3 Eli Lilly and Company Financial Information
                8.4.5.4 Eli Lilly and Company Product Positions/Portfolio
                8.4.5.5 Eli Lilly and Company Key Developments
        8.4.6 Merck and Co., Inc.
                8.4.6.1 Business Description
                8.4.6.2 Merck and Co., Inc. Geographic Operations
                8.4.6.3 Merck and Co., Inc. Financial Information
                8.4.6.4 Merck and Co., Inc. Product Positions/Portfolio
                8.4.6.5 Merck and Co., Inc. Key Developments
        8.4.7 Sanofi S.A
                8.4.7.1 Business Description
                8.4.7.2 Sanofi S.A Geographic Operations
                8.4.7.3 Sanofi S.A Financial Information
                8.4.7.4 Sanofi S.A Product Positions/Portfolio
                8.4.7.5 Sanofi S.A Key Developments
        8.4.8 Vetoquinol
                8.4.8.1 Business Description
                8.4.8.2 Vetoquinol Geographic Operations
                8.4.8.3 Vetoquinol Financial Information
                8.4.8.4 Vetoquinol Product Positions/Portfolio
                8.4.8.5 Vetoquinol Key Developments
        8.4.9 Zoetis, Inc.
                8.4.9.1 Business Description
                8.4.9.2 Zoetis, Inc. Geographic Operations
                8.4.9.3 Zoetis, Inc. Financial Information
                8.4.9.4 Zoetis, Inc. Product Positions/Portfolio
                8.4.9.5 Zoetis, Inc. Key Developments
        8.4.10 Hipra
                8.4.10.1 Business Description
                8.4.10.2 Hipra Geographic Operations
                8.4.10.3 Hipra Financial Information
                8.4.10.4 Hipra Product Positions/Portfolio
                8.4.10.5 Hipra Key Developments
        8.4.11 Elanco
                8.4.11.1 Business Description
                8.4.11.2 Elanco Geographic Operations
                8.4.11.3 Elanco Financial Information
                8.4.11.4 Elanco Product Positions/Portfolio
                8.4.11.5 Elanco Key Developments
        8.4.12 Formosa Biomedical Inc.
                8.4.12.1 Business Description
                8.4.12.2 Formosa Biomedical Inc. Geographic Operations
                8.4.12.3 Formosa Biomedical Inc. Financial Information
                8.4.12.4 Formosa Biomedical Inc. Product Positions/Portfolio
                8.4.12.5 Formosa Biomedical Inc. Key Developments
        8.4.13 Shoken Pharmaceutical Co., Ltd
                8.4.13.1 Business Description
                8.4.13.2 Shoken Pharmaceutical Co., Ltd Geographic Operations
                8.4.13.3 Shoken Pharmaceutical Co., Ltd Financial Information
                8.4.13.4 Shoken Pharmaceutical Co., Ltd Product Positions/Portfolio
                8.4.13.5 Shoken Pharmaceutical Co., Ltd Key Developments
        8.4.14 MSD Animal Health
                8.4.14.1 Business Description
                8.4.14.2 MSD Animal Health Geographic Operations
                8.4.14.3 MSD Animal Health Financial Information
                8.4.14.4 MSD Animal Health Product Positions/Portfolio
                8.4.14.5 MSD Animal Health Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Porcine Vaccine Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Porcine Vaccine Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Porcine Vaccine Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Porcine Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Porcine Vaccine Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Porcine Vaccine Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Porcine Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Porcine Vaccine Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Porcine Vaccine Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Porcine Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Porcine Vaccine Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Porcine Vaccine Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Porcine Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Porcine Vaccine Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Porcine Vaccine Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Porcine Vaccine Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Porcine Vaccine: Market Segmentation 
FIG. 2 Global Porcine Vaccine Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Porcine Vaccine Market, By Technology, 2019 (US$ Mn) 
FIG. 5 Global Porcine Vaccine Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Porcine Vaccine Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Porcine Vaccine Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Porcine Vaccine Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Porcine Vaccine Providers, 2019
FIG. 11 Global Porcine Vaccine Market Revenue Contribution, By Technology, 2019 & 2028 (Value %) 
FIG. 12 Global Porcine Vaccine Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Porcine Vaccine Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Porcine Vaccine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Porcine Vaccine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Porcine Vaccine Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Porcine Vaccine Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Porcine Vaccine Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Porcine Vaccine market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Porcine Vaccine Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Porcine Vaccine Market Value, By Segment1, 2018 – 2028
TABLE  North America Porcine Vaccine Market Value, By Segment2, 2018 – 2028
TABLE  North America Porcine Vaccine Market Value, By Country, 2018 – 2028
TABLE  Europe Porcine Vaccine Market Value, By Segment1, 2018 – 2028
TABLE  Europe Porcine Vaccine Market Value, By Segment2, 2018 – 2028
TABLE  Europe Porcine Vaccine Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Porcine Vaccine Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Porcine Vaccine Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Porcine Vaccine Market Value, By Country, 2018 – 2028
TABLE  Latin America Porcine Vaccine Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Porcine Vaccine Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Porcine Vaccine Market Value, By Country, 2018 – 2028
TABLE  MEA Porcine Vaccine Market Value, By Segment1, 2018 – 2028
TABLE  MEA Porcine Vaccine Market Value, By Segment2, 2018 – 2028
TABLE  MEA Porcine Vaccine Market Value, By Country, 2018 – 2028
TABLE  Bayer AG: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bimeda Animal Health: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Boehringer Ingelheim GmbH: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Ceva Sante Animale: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Eli Lilly and Company: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Merck and Co., Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Sanofi S.A: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Vetoquinol: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Zoetis, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Hipra: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Elanco: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Formosa Biomedical Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Shoken Pharmaceutical Co., Ltd: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  MSD Animal Health: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Porcine Vaccine Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Porcine Vaccine Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Porcine Vaccine Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Porcine Vaccine Market, By Geography, 2019 (US$ Mn)
FIG.  Global Porcine Vaccine Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Porcine Vaccine Providers, 2016
FIG.  Global Porcine Vaccine Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global Live Attenuated Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Toxoid Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Recombinant Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Conjugate Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global DNA Vaccines Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Porcine Vaccine Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Hog/Pig Production Farm Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Porcine Vaccine Market Value, 2018 – 2028, (US$ Mn)